Impact of denosumab on bone mass in cancer patients
Ursa Brown-Glaberman, Alison T StopeckUniversity of Arizona Cancer Center, Tucson, AZ, USAAbstract: Cancer therapy-induced bone loss (CTIBL) is a form of secondary osteoporosis associated with systemic chemotherapy and hormonal ablation therapy. The monitoring and treatment of CTIBL is an important...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2013-07-01
|
| Series: | Clinical Pharmacology : Advances and Applications |
| Online Access: | http://www.dovepress.com/impact-of-denosumab-on-bone-mass-in-cancer-patients-a13568 |